Synergistic stimulation of osteoblast differentiation of rat mesenchymal stem cells by leptin and 25(OH)D3 is mediated by inhibition of chaperone-mediated autophagy
Open Access
- 30 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Stem Cell Research & Therapy
- Vol. 12 (1), 1-13
- https://doi.org/10.1186/s13287-021-02623-z
Abstract
Vitamin D is important for the mineralization of bones by stimulating osteoblast differentiation of bone marrow mesenchymal stem cells (BMMSCs). BMMSCs are a target of vitamin D action, and the metabolism of 25(OH)D3 to biologically active 1α,25(OH)2D3 in BMMSCs promotes osteoblastogenesis in an autocrine/paracrine manner. Our previous study with human BMMSCs showed that megalin is required for the 25(OH)D3-DBP complex to enter cells and for 25(OH)D3 to stimulate osteoblast differentiation in BMMSCs. Furthermore, we reported that leptin up-regulates megalin in those cells. Leptin is a known inhibitor of PI3K/AKT-dependent chaperone-mediated autophagy (CMA). In this study, we tested the hypothesis that leptin acts synergistically with 25(OH)D3 to promote osteoblastogenesis in rat BMMSCs by a mechanism that entails inhibition of PI3K/AKT-dependent CMA. BMMSCs were isolated from rat bone marrow (4-week-old male SD rats); qRT-PCR and western immunoblots or immunofluorescence were used to evaluate the expression of megalin, ALP, COL1A1, RUNX2, OSX, OSP, and CMA in rBMMSCs. The osteoblast differentiation was evaluated by ALP activity, ALP staining, and calcium deposition. The viability of rBMMSCs was assessed with the CCK-8 kit. Biosynthesis of 1α,25(OH)2D3 was measured by a Rat 1α,25(OH)2D3 ELISA Kit. The combination of leptin and 25(OH)D3 treatment significantly enhanced osteoblast differentiation as shown by ALP activity, ALP staining, and calcium deposition, the expression of osteogenic genes ALP, COL1A1, RUNX2, OSX, and OSP by qRT-PCR and western immunoblots in rBMMSCs. Leptin enhanced the expression of megalin and synthesis of 1α,25(OH)2D3 in rBMMSCs. Our data showed that leptin inhibited CMA activity of rBMMSCs by activating PI3K/AKT signal pathway; the ability of leptin to enhance 25(OH)D3 promoted osteoblast differentiation of rBMMSCs was weakened by the PI3K/AKT signal pathway inhibitor. Our data reveal the mechanism by which leptin and 25(OH)D3 promote osteoblast differentiation in rBMMSCs. Leptin promoted the expression of megalin by inhibiting CMA, increased the utilization of 25(OH)D3 by rBMMSCs, and enhanced the ability of 25(OH)D3 to induce osteoblast differentiation of rBMMSCs. PI3K/AKT is at least partially involved in the regulation of CMA. These data indicate the importance of megalin in BMMSCs for vitamin D’s role in skeletal health.Keywords
Funding Information
- National Key Research and Development Program of China (2020YFC2009000)
- Natural Science Foundation of Shandong Province (2019GSF108029, ZR2020QH090)
- Shandong University Qilu Hospital Clinical Practical New Technology Fund (2019-8)
This publication has 51 references indexed in Scilit:
- Age‐related decline in osteoblastogenesis and 1α‐hydroxylase/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormoneAging Cell, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowJournal of Clinical Endocrinology & Metabolism, 2011
- Effects of obesity on bone metabolismJournal of Orthopaedic Surgery and Research, 2011
- Vitamin D supplementation: a pharmacologic perspectiveCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- What old means to boneTrends in Endocrinology & Metabolism, 2010
- Leptin Functions Peripherally to Regulate Differentiation of Mesenchymal Progenitor CellsThe International Journal of Cell Cloning, 2010
- PET Imaging of Leptin Biodistribution and Metabolism in Rodents and PrimatesCell Metabolism, 2009
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Evidence for auto/paracrine actions of vitamin D in bone: 1a‐hydroxylase expression and activity in human bone cellsThe FASEB Journal, 2006
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999